Zura Bio Ltd (ZURA) Stock Price, Quote & News

Company Profile

Zura Bio Limited, a clinical-stage biotechnology company, develops medicines for immune and inflammatory disorders in the United States. The company develops Tibulizumab, an immunoglobulin G-single-chain variable fragment bispecific dual-antagonist antibody engineered by the fusion of ixekizumab and tabalumab that neutralizes interleukin (IL)-17A and B-cell activating factor, which is in Phase 2 clinical trial development. It is also developing Torudokimab (ZB-880), a monoclonal antibody that ne...

Industry: Biotechnology

Sector: Healthcare

Phone: 702 825 9872

Website: zurabio.com

Address:

1489 W. Warm Springs Road, Suite 110, Henderson, United States

JarvisFlow Nov. 14 at 8:55 PM

Chardan Capital has updated their rating for Zura Bio ( $ZURA ) to Buy with a price target of 10.

0 · Reply

d_risk Nov. 13 at 1:30 PM

$ZURA - Zura Bio Limited Class A Ordinary Shares - 10Q - Updated Risk Factors Zura flags heightened regulatory disruption risks from agency shutdowns, new uncertainties in clinical trial outcomes, intensifying competition, potential adverse impacts from healthcare reforms, stricter data privacy compliance challenges, and dependence on attracting and retaining key personnel. #Biotechnology #DataPrivacy #HealthcareReform #ClinicalTrials #RegulatoryRisk 🟢 Added 🟠 Removed https://d-risk.ai/ZURA/10-Q/2025-11-13

0 · Reply

JarvisFlow Nov. 13 at 11:12 AM

Clear Street updates rating for Zura Bio ( $ZURA ) to Buy, target set at 18.

0 · Reply

CAN_2409 Nov. 12 at 10:58 AM

$ZURA survival data at CADL is huge!

0 · Reply

PiratesKingLuffy Nov. 12 at 3:08 AM

AMZE Expecting a big move here tomorrow. Very bullish close today!! AMZE has extended its partnership with Adobe Express, expanding platform access to creators in India — a market with over 2 million monetized creators and $350B in consumer spending. The integration lets users design and sell custom merchandise directly on Amaze, streamlining the path from creation to commerce. The expansion follows Amaze’s showcase at Adobe MAX 2025. Lets bank on AMZE such a gem here! $BMNR $WLDS $ZURA $GDC..1

0 · Reply

SadyK189 Nov. 12 at 2:29 AM

Top Stocks to watch tomorrow 2 / 2: $RIVN $LUCY $IRWD $ZURA $XBIT RIVN: Looking good on daily chart. 16.10 - 16.60 is acting as key support zone. Next key level to test is 19.60 - 20.10. Overall it has long term potential of 24+ ZURA: Good close of daily candle. Key support at 3.4 - 3.8. Next key level to test is 4.95 - 5.30. Currently at 4.41. IRWD is trending nicely on daily chart. 2.15 - 2.35 is acting as key support zone. Next key level to test is 3.35 - 3.55. Currently at 2.95 LUCY: Good close of 4hours candle. Key support at 1.55 - 1.70. Next key level to test is 2.6 - 2.9. Currently at 2.17 XBIT tried to clear stiff resistance of 3.3 - 3.6 zone today but got rejected. Currently at 2.83. It may test this zone again.

0 · Reply

Breck100 Nov. 11 at 12:15 PM

$ZURA earnings today?

1 · Reply

Hollandaise56 Nov. 4 at 9:10 PM

$ZURA what's happening here...

0 · Reply

deniz100 Oct. 27 at 11:25 PM

$ZURA Tommorows runner. 100% move expected!

1 · Reply

djotc Oct. 27 at 10:54 PM

$ZURA why are so many ppl high on this stock? Analysts calling for $26 pt and stockinvest calling for $11 in the next 90 days. Im in!

0 · Reply

Zura Bio Reports Third Quarter 2025 Financial Results and Recent Corporate Updates

Aug 20, 2025, 6:30 AM EDT - 3 months ago

Zura Bio to Participate in the Cantor Fitzgerald Global Healthcare Conference

Aug 14, 2025, 8:15 AM EDT - 3 months ago

Zura Bio Reports Second Quarter 2025 Financial Results and Recent Corporate Updates

Jul 17, 2025, 4:30 PM EDT - 4 months ago

Zura Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Jul 1, 2025, 6:30 AM EDT - 4 months ago

Zura Bio Announces Chief Financial Officer Transition

May 27, 2025, 6:30 AM EDT - 6 months ago

Zura Bio to Present at the Jefferies Global Healthcare Conference

May 20, 2025, 6:30 AM EDT - 6 months ago

Zura Bio Launches Global Phase 2 TibuSHIELD Study to Evaluate Tibulizumab in Adults with Hidradenitis Suppurativa

May 8, 2025, 6:30 AM EDT - 6 months ago

Zura Bio Reports First Quarter 2025 Financial Results and Recent Corporate Updates

Mar 25, 2025, 6:30 AM EDT - 8 months ago

Zura Bio Reports Full Year 2024 Financial Results and Recent Corporate Updates

Feb 24, 2025, 6:30 AM EST - 9 months ago

Zura Bio to Present at the Leerink Partners Global Healthcare Conference

Dec 23, 2024, 6:30 AM EST - 11 months ago

Zura Bio Launches Global Phase 2 TibuSURE Study to Evaluate Tibulizumab in Adults With Systemic Sclerosis

Nov 25, 2024, 6:30 AM EST - 1 year ago

Zura Bio to Present at the Piper Sandler 36th Annual Healthcare Conference

Nov 14, 2024, 4:30 PM EST - 1 year ago

Zura Bio Announces Submission of Protocol to U.S. Food and Drug Administration for the Phase 2 Study of Tibulizumab in Adults with Systemic Sclerosis

Nov 7, 2024, 6:30 AM EST - 1 year ago

Zura Bio Reports Third Quarter 2024 Financial Results and Recent Corporate Updates

Oct 30, 2024, 6:30 AM EDT - 1 year ago

Zura Bio to Participate in Two Upcoming Investor Conferences in November

Sep 3, 2024, 6:00 AM EDT - 1 year ago

CPS HR Consulting Partners with GovInvest to Revolutionize Compensation Consulting with Advanced Technology

OGI

Sep 3, 2024, 6:00 AM EDT - 1 year ago

Zura Bio to Present at Three Upcoming Investor Conferences in September

Aug 13, 2024, 9:21 AM EDT - 1 year ago

Zura Bio Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Aug 12, 2024, 4:05 PM EDT - 1 year ago

Zura Bio Completes Exchange Offer and Consent Solicitation and Notice to Exercise Right to Exchange Remaining Outstanding Warrants

Aug 9, 2024, 4:05 PM EDT - 1 year ago

Zura Bio Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to its Warrants

Jul 12, 2024, 6:10 AM EDT - 1 year ago

Zura Bio Commences Warrant Exchange Offer and Consent Solicitation

Jun 14, 2024, 6:00 AM EDT - 1 year ago

Zura Bio Presents Data for the Tibulizumab (ZB-106) Program at EULAR 2024

Jun 6, 2024, 6:00 AM EDT - 1 year ago

Zura Bio Forms Scientific Advisory Board with Prominent Specialists in Rheumatology, Dermatology, and Immunology

Jun 3, 2024, 6:00 AM EDT - 1 year ago

Zura Bio to Present Data Exploring the Expanded Potential of Tibulizumab (ZB-106) into Sjogren's Syndrome and Rheumatoid Arthritis at EULAR 2024

May 29, 2024, 6:00 AM EDT - 1 year ago

Zura Bio Announces Participation in June Investor Conferences

May 9, 2024, 6:00 AM EDT - 1 year ago

Zura Bio Reports First Quarter 2024 Financial Results and Recent Business Highlights

Apr 18, 2024, 9:22 AM EDT - 1 year ago

Zura Bio Announces Oversubscribed $112.5 Million Private Placement

Apr 8, 2024, 6:00 AM EDT - 1 year ago

Zura Bio Announces Robert Lisicki as CEO and Director

Mar 28, 2024, 6:00 AM EDT - 1 year ago

Zura Bio Reports Full Year 2023 Financial Results, Business Highlights, and Appoints Robert Lisicki as Chief Executive Officer

Mar 4, 2024, 6:00 AM EST - 1 year ago

Zura Bio Announces Participation at March Conferences

Feb 2, 2024, 6:00 AM EST - 1 year ago

Zura Bio Announces Participation at February Investor Conferences

Jan 8, 2024, 6:00 AM EST - 2 years ago

Zura Bio Continues to Strengthen Leadership with Appointment of Robert Lisicki as President and Kiran Nistala as CMO

Jan 3, 2024, 6:00 AM EST - 2 years ago

Zura Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference and Dermatology Summit

Dec 4, 2023, 6:00 AM EST - 2 years ago

Zura Bio Announces Two Immunology Abstracts Presented at the World Allergy Congress in Bangkok

Nov 14, 2023, 6:00 AM EST - 2 years ago

Zura Bio Appoints Arnout Ploos van Amstel to its Board of Directors

Nov 13, 2023, 6:30 AM EST - 2 years ago

Zura Bio Reports Third Quarter 2023 Financial Results and Recent Business Highlights

Sep 12, 2023, 5:00 AM EDT - 2 years ago

Zura Bio Enters into Sponsored Research Agreement with Benaroya Research Institute

Aug 14, 2023, 7:00 AM EDT - 2 years ago

Zura Bio Reports Second Quarter 2023 Financial Results and Recent Business Highlights

Jun 23, 2023, 6:30 AM EDT - 2 years ago

Zura Bio to Join the Russell 2000® and Russell 3000® Indexes

Jun 6, 2023, 4:00 AM EDT - 2 years ago

Zura Bio Completes Approximately $80 Million Financing with the Focus on Advancing ZB-106, a Potential First-in-class Anti-IL-17 and Anti-BAFF Dual Antagonist

Apr 27, 2023, 7:39 AM EDT - 2 years ago

Zura Bio Announces $80 Million Financing and the Licensing of Tibulizumab (ZB-106), a Potential First-in-Class anti-IL-17 and anti-BAFF Dual Antagonist for Autoimmune Diseases

Apr 14, 2023, 5:00 AM EDT - 2 years ago

Zura Bio Announces Appointment of Chief Scientific Officer

Mar 21, 2023, 6:13 AM EDT - 2 years ago

Zura Bio Limited Announces Closing of Business Combination with JATT Acquisition Corp

Mar 16, 2023, 4:17 PM EDT - 2 years ago

JATT Acquisition Corp Shareholders Approve Proposed Business Combination with Zura Bio Limited

JarvisFlow Nov. 14 at 8:55 PM

Chardan Capital has updated their rating for Zura Bio ( $ZURA ) to Buy with a price target of 10.

0 · Reply

d_risk Nov. 13 at 1:30 PM

0 · Reply

JarvisFlow Nov. 13 at 11:12 AM

Clear Street updates rating for Zura Bio ( $ZURA ) to Buy, target set at 18.

0 · Reply

CAN_2409 Nov. 12 at 10:58 AM

$ZURA survival data at CADL is huge!

0 · Reply

PiratesKingLuffy Nov. 12 at 3:08 AM

0 · Reply

SadyK189 Nov. 12 at 2:29 AM

0 · Reply

Breck100 Nov. 11 at 12:15 PM

$ZURA earnings today?

1 · Reply

Hollandaise56 Nov. 4 at 9:10 PM

$ZURA what's happening here...

0 · Reply

deniz100 Oct. 27 at 11:25 PM

$ZURA Tommorows runner. 100% move expected!

1 · Reply

djotc Oct. 27 at 10:54 PM

$ZURA why are so many ppl high on this stock? Analysts calling for $26 pt and stockinvest calling for $11 in the next 90 days. Im in!

0 · Reply

invinc1ble Oct. 25 at 3:26 PM

$ZURA sleeper. Watch it

0 · Reply

octavia8 Oct. 14 at 2:00 PM

$ZURA v shaped recovery??

0 · Reply

jerry_berlin Oct. 13 at 3:53 PM

$ZURA why is it going down?

2 · Reply

TraderJay85 Oct. 10 at 5:34 PM

$ZURA Big win! 🔥 🔥 Went to 4.58. Got in early. We had over 10 poppers so far today. If you are not hitting at least 3 runners a day, then you aint doin something right. NO EMAILS NO DISCORDS JUST FREE IDEAS TO EVERYONE. HIT THE FOLLOW AND LETS MAKE MONEY TOGETHER

1 · Reply

AStrokeOfLuck Oct. 10 at 1:01 PM

$ZURA

1 · Reply

kkbb Oct. 10 at 12:32 PM

$ZURA https://investors.zurabio.com/node/9026/html Zura Bio’s CEO, Robert Lisicki, is taking a medical leave of absence effective October 10, 2025. The company’s COO and Chief Legal Officer, Kim Davis, has been appointed interim CEO while continuing her current roles.

0 · Reply

stockthoughts9282 Oct. 9 at 5:00 PM

I bought two shares of $ZURA last year just because I thought the name sounded funny and obviously I now wish I'd bought hundreds, because it's up 150%. What exactly do they produce or do? Can someone explain? Or is this just a pump and dump on a penny stock? Thanks.

1 · Reply

jerry_berlin Oct. 8 at 7:28 PM

$ZURA yes beauty slow and stady✨

0 · Reply

BassmanOH Oct. 8 at 2:39 AM

$ZURA Complete and Utter WOW

1 · Reply

jerry_berlin Oct. 7 at 4:43 PM

$ZURA Slow and stady 🐂💚

0 · Reply

Great_Stuff_coming Oct. 6 at 7:55 PM

$MLTX switch to $ZURA . Thank Me in 5 days.

1 · Reply

deniz100 Oct. 6 at 6:54 PM

$ZURA consolidating for $8

0 · Reply

Market Cap	271.78M
Revenue (ttm)	0.00
Net Income (ttm)	-45.39M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	398,300
Avg Vol	2,002,164
Day's Range	N/A - N/A
Shares Out	65.02M
Stochastic %K	55%
Beta	0.24
Analysts	Strong Sell
Price Target	$13.33